2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build

2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This is not an authorized publication; it is the continuous build for version 2022.1.0). This version is based on the current content of https://github.com/cqframework/opioid-cds-r4/ and changes regularly. See the Directory of published versions

Table of Contents

...0 Table of Contents
...1 Home
...2 2022 CDC Clinical Practice Guideline - Profiles
...3 2022 CDC Clinical Practice Guideline - Terminology
...4 2022 CDC Clinical Practice Guideline - Examples
....5 2022 CDC Clinical Practice Guideline - Documentation
....5.1 2022 CDC Clinical Practice Guideline - Implementation Documentation
....5.2 2022 CDC Clinical Practice Guideline - Integration Documentation
....5.3 2022 CDC Clinical Practice Guideline - Process Documentation
....5.4 2022 CDC Clinical Practice Guideline - Service Documentation
...6 2022 CDC Clinical Practice Guideline - Downloads
...7 2022 CDC Clinical Practice Guideline - Acute Pain
...8 2022 CDC Clinical Practice Guideline - Quick Start
...9 2022 CDC Clinical Practice Guideline - Extensions
...10 2022 CDC Clinical Practice Guideline - Operations
...11 Conformance Resource Registry
...12 2022 CDC Clinical Practice Guideline - Services
...13 Chronic Pain Decision Documentation
....14 Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration
....14.1 OpioidCDS Recommendation 01 - CQL Source
....15 Recommendation #2 - Opioid Therapy Goals Discussion
....15.1 OpioidCDS Recommendation 02 - CQL Source
....16 Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy
....16.1 OpioidCDS Recommendation 03 - CQL Source
....17 Recommendations #4 and #5 - Lowest Effective Dose
....17.1 OpioidCDS Recommendations 04 and 05 - CQL Source
....18 Recommendation #6 - Prescribe Lowest Effective Dose and Duration
....18.1 OpioidCDS Recommendation 06 - CQL Source
....19 Recommendation #7 - Opioid Therapy Risk Assessment
....19.1 OpioidCDS Recommendation 07 - CQL Source
....20 Recommendation #8 - Naloxone Consideration
....20.1 OpioidCDS Recommendation 08 - CQL Source
....21 Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions
....21.1 OpioidCDS Recommendation 09 - CQL Source
....22 Recommendation #10 Order Sign Variation - Urine Drug Testing
....22.1 OpioidCDS Recommendation 10 Order Sign - CQL Source
....23 Recommendation #10 Patient View Variation - Urine Drug Testing
....23.1 OpioidCDS Recommendation 10 Patient View - CQL Source
....24 Recommendation #11 Order Select Variation - Concurrent Use of Opioids and Benzodiazepines
....24.1 OpioidCDS Recommendation 11 Order Select - CQL Source
....25 Recommendation #11 Patient View Variation - Concurrent Use of Opioids and Benzodiazepines
....25.1 OpioidCDS Recommendation 11 Patient View - CQL Source
....26 Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder
....26.1 OpioidCDS Recommendation 12 (patient-view) - CQL Source
...27 License and Legal Terms
....28 Artifacts Summary
....28.1 HelloWorld
....28.2 HelloWorldPatientView
....28.3 CDCMMEClinicalConversionFactors
....28.4 OpioidCDSRoutines
....28.5 OpioidCDSCommon
....28.6 OpioidCDSCommonConfig
....28.7 OpioidLogicMK2020
....28.8 OpioidData2020
....28.9 FHIRHelpers
....28.10 FHIRModelInfo
....28.11 OpioidCDSREC10CommonLibrary
....28.12 OpioidCDSREC01Library
....28.13 OpioidCDSREC02Library
....28.14 OpioidCDSREC03Library
....28.15 OpioidCDSREC04And05Library
....28.16 OpioidCDSREC06Library
....28.17 OpioidCDSREC07Library
....28.18 OpioidCDSREC08Library
....28.19 OpioidCDSREC09Library
....28.20 OpioidCDSREC10Library
....28.21 OpioidCDSREC10PatientViewLibrary
....28.22 OpioidCDSREC11Library
....28.23 OpioidCDSREC11PatientViewLibrary
....28.24 OpioidCDSREC12PatientViewLibrary
....28.25 OpioidRiskAssessmentActivityDefinition
....28.26 OpioidUrineScreeningActivityDefinition
.....28.27 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (order-sign)
.....28.27.1 Library
.....28.28 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #6
.....28.28.1 Library
.....28.29 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8
.....28.29.1 Library
.....28.30 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8 (order-sign)
.....28.30.1 Library
.....28.31 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (patient-view)
.....28.31.1 Library
.....28.32 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendations #4 and #5
.....28.32.1 Library
.....28.33 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #7
.....28.33.1 Library
.....28.34 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #1
.....28.34.1 Library
.....28.35 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #3
.....28.35.1 Library
.....28.36 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #2
.....28.36.1 Library
.....28.37 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #12 (patient-view)
.....28.37.1 Library
.....28.38 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11
.....28.38.1 Library
.....28.39 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #9
.....28.39.1 Library
.....28.40 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11 (patient-view)
.....28.40.1 Library
.....28.41 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10
.....28.41.1 Library
....28.42 Opioid Management Terminology Knowledge Data
....28.43 Morphine Milligram Equivalent (MME) Conversion Factors for FHIR R4
....28.44 Morphine Milligram Equivalent (MME) Calculator for FHIR R4
....28.45 Opioid Management Terminology Knowledge Logic
....28.46 Library - OMTK Logic MK (2019)
....28.47 Library - OMTK Data (2019)
....28.48 CDC_CarePlan
....28.49 CDC_MedicationRequest
....28.50 CDC_Observation
....28.51 CDC_RequestGroup
....28.52 CDC-ValueSet
....28.53 DataDateRollerExtension
....28.54 CDC 2022 Opioid Guidance Inclusion Criteria Extension
....28.55 CDC 2022 Opioid Guidance Clinical Focus Extension
....28.56 CDC 2022 Opioid Guidance exclusion Criteria Extension
....28.57 CDC 2022 Opioid Guidance Data Element Extension
....28.58 Action_indicator
....28.59 Extended release opioid with ambulatory misuse potential
....28.60 Non-opioid drug urine screening
....28.61 Substance misuse behavioral counseling
....28.62 ValueSet - Hospice Disposition
....28.63 Fentanyl-type medications
....28.64 Amphetamine-class drugs and metabolite urine tests
....28.65 Opioid misuse assessment procedure
....28.66 Opioid analgesics with ambulatory misuse potential
....28.67 CDC malignant cancer conditions
....28.68 Cannabinoid class urine drug screening
....28.69 Ethanol urine drug screening tests
....28.70 Oncology specialty designations (NUCC)
....28.71 Sickle-cell diseases
....28.72 Naloxone medications
....28.73 Limited life expectancy conditions
....28.74 General opiate urine drug screening tests
....28.75 Benzodiazepine medications
....28.76 Opioid drug urine screening
....28.77 Methadone urine drug screening tests
....28.78 ValueSet - Opioid Indicator
....28.79 Methadone medications
....28.80 ValueSet - Problem List Condition Category
....28.81 Therapies indicating end of life care
....28.82 PDMP data reviewed finding
....28.83 Conditions documenting substance misuse
....28.84 Hospice Procedure
....28.85 Ambulatory setting non-opioid CNS depressant medications
....28.86 Synthetic opioid medications
....28.87 Non-synthetic opioid medications
....28.88 ValueSet - Observation Category Procedure
....28.89 ValueSet - US Core Health Concern Condition Category
....28.90 ValueSet - Encounter Diagnosis Condition Categories
....28.91 Sleep disordered breathing
....28.92 Amphetamine class medications
....28.93 Pain treatment plan
....28.94 Hospice Finding
....28.95 Opiate specific urine drug screening tests
....28.96 Phencyclidine urine drug screening tests
....28.97 Opioid treatment assessment procedure
....28.98 Pain management procedure
....28.99 Synthetic opioid urine drug screening tests
....28.100 Opioid counseling procedure
....28.101 Fentanyl-type urine drug screening tests
....28.102 Cocaine urine drug screening tests
....28.103 ValueSet - Condition Clinical Status Active
....28.104 Opioid misuse disorders
....28.105 PDMP review procedure
....28.106 CNS depressant medications
....28.107 ValueSet - Observation Category Laboratory
....28.108 Buprenorphine and Methadone medications
....28.109 ValueSet - Office Visit
....28.110 Conditions likely terminal for opioid prescribing
....28.111 CodeSystem - CDC 2022 Opioid Indicator
....28.112 OpioidCDS CarePlan
....28.113 Cancer Diagnosis Condition
....28.114 End of Life Condition
....28.115 Terminal Condition
....28.116 Cancer Diagnosis Encounter
....28.117 Oncology Participant Encounter
....28.118 Ambulatory Opioid MedicationDispense
....28.119 OpioidCDS MedicationRequest
....28.120 Ambulatory Opioid MedicationRequest
....28.121 OpioidCDS Observation
....28.122 OpioidCDS Patient
....28.123 Oncology Specialist PractitionerRole
....28.124 OpioidCDS RequestGroup
....28.125 Palliative Care ServiceRequest
....28.126 CQFToolingDevice